Provided by Tiger Trade Technology Pte. Ltd.

Milestone Pharmaceuticals Inc.

0.8657
+0.04575.57%
Post-market: 0.8500-0.0157-1.81%19:30 EDT
Volume:1.27M
Turnover:1.10M
Market Cap:107.35M
PE:-1.28
High:0.8975
Open:0.8380
Low:0.8200
Close:0.8200
52wk High:3.06
52wk Low:0.7521
Shares:124.00M
Float Shares:106.47M
Volume Ratio:0.98
T/O Rate:1.19%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6748
EPS(LYR):-0.7517
ROE:-35522.62%
ROA:-42.78%
PB:5.89
PE(LYR):-1.15

Loading ...

Milestone Shares Fall on Unexpected 1Q Loss

Dow Jones
·
May 13

Canada's Milestone Pharmaceuticals Q1 revenue misses estimates after CARDAMYST launch

Reuters
·
May 13

Milestone Pharmaceuticals Announces First Quarter 2026 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
May 13

Milestone Pharmaceuticals Q1 Revenue USD 238 Thousand VS. Ibes Estimate USD 37.6 Million

THOMSON REUTERS
·
May 13

Milestone Pharma Q1 net loss widens 25.6% to $26.07 million

Reuters
·
May 13

Milestone Pharmaceuticals Q1 EPS $(0.20) Misses $0.14 Estimate, Sales $238.000K

Benzinga Earnings
·
May 13

Milestone Pharmaceuticals Inc expected to post earnings of 31 cents a share - Earnings Preview

Reuters
·
May 11

Milestone Pharmaceuticals to report Q1 2026 results, host investor call

Reuters
·
May 06

Milestone Pharmaceuticals announces annual shareholder meeting

Reuters
·
May 01

Milestone Pharma CEO Joseph Oliveto disposes of 36,500 shares for $82,490

Reuters
·
Apr 21

Milestone launches Phase 4 RESET-PSVT registry for CARDAMYST nasal spray in adults

Reuters
·
Apr 10

Milestone Pharmaceuticals Announces Reset-Psvt Registry to Generate Real-World Evidence on Cardamyst™ (Etripamil) Nasal Spray in Patients With Psvt

THOMSON REUTERS
·
Apr 10

Milestone Pharma to Present at Needham Virtual Healthcare Conference

Reuters
·
Apr 07

Milestone Pharmaceuticals grants 123,000 inducement stock options to new hires

Reuters
·
Apr 02

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Apr 02

Milestone says Express Scripts adds CARDAMYST to commercial national formularies

Reuters
·
Apr 01

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (SNY), Milestone Pharmaceuticals (MIST) and Connect Biopharma Holdings (CNTB)

TIPRANKS
·
Mar 31